Volitionrx (VNRX) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026)
Volitionrx (VNRX) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 5.69% |
| 10 | Volitionrx | 1.13 Mn | -1.66 Mn | - | -20.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.80% |
| Dec 31, 2025 | -9.06% |
| Sep 30, 2025 | -13.54% |
| Jun 30, 2025 | -7.76% |
| Mar 31, 2025 | -16.06% |
| Dec 31, 2024 | -19.81% |
| Sep 30, 2024 | -7.48% |
| Jun 30, 2024 | -10.58% |
| Mar 31, 2024 | -4.10% |
| Dec 31, 2023 | 2.41% |
| Sep 30, 2023 | 8.69% |
| Jun 30, 2023 | 13.47% |
| Mar 31, 2023 | 14.42% |
| Dec 31, 2022 | 9.81% |
| Sep 30, 2022 | -3.95% |
| Jun 30, 2022 | -8.71% |
| Dec 31, 2021 | -5.03% |
| Dec 31, 2020 | 73.46% |
| Dec 31, 2019 | -4.44% |
| Jun 30, 2013 | -3.80% |